19 results on '"Irmler, Martin"'
Search Results
2. Secretome profiling of primary human skeletal muscle cells
- Author
-
Hartwig, Sonja, Raschke, Silja, Knebel, Birgit, Scheler, Mika, Irmler, Martin, Passlack, Waltraud, Muller, Stefan, Hanisch, Franz-Georg, Franz, Thomas, Li, Xinping, Dicken, Hans-Dieter, Eckardt, Kristin, Beckers, Johannes, de Angelis, Martin Hrabe, Weigert, Cora, Häring, Hans-Ulrich, Al-Hasani, Hadi, Ouwens, D. Margriet, Eckel, Jürgen, Kotzka, Jorg, and Lehr, Stefan
- Published
- 2014
- Full Text
- View/download PDF
3. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
- Author
-
Irmler, Martin, Steiner, Véronique, Ruegg, Curzio, Wajant, Harald, and Tschopp, Jürg
- Published
- 2000
- Full Text
- View/download PDF
4. Point mutations in the PDX1 transactivation domain impair human β-cell development and function.
- Author
-
Wang, Xianming, Sterr, Michael, Ansarullah, Burtscher, Ingo, Böttcher, Anika, Beckenbauer, Julia, Siehler, Johanna, Meitinger, Thomas, Häring, Hans-Ulrich, Staiger, Harald, Cernilogar, Filippo M., Schotta, Gunnar, Irmler, Martin, Beckers, Johannes, Wright, Christopher V.E., Bakhti, Mostafa, and Lickert, Heiko
- Abstract
Hundreds of missense mutations in the coding region of PDX1 exist; however, if these mutations predispose to diabetes mellitus is unknown. In this study, we screened a large cohort of subjects with increased risk for diabetes and identified two subjects with impaired glucose tolerance carrying common, heterozygous, missense mutations in the PDX1 coding region leading to single amino acid exchanges (P33T, C18R) in its transactivation domain. We generated iPSCs from patients with heterozygous PDX1
P33T/+ , PDX1C18R/+ mutations and engineered isogenic cell lines carrying homozygous PDX1P33T/P33T , PDX1C18R/C18R mutations and a heterozygous PDX1 loss-of-function mutation (PDX1+/− ). Using an in vitro β-cell differentiation protocol, we demonstrated that both, heterozygous PDX1P33T/+ , PDX1C18R/+ and homozygous PDX1P33T/P33T , PDX1C18R/C18R mutations impair β-cell differentiation and function. Furthermore, PDX1+/− and PDX1P33T/P33T mutations reduced differentiation efficiency of pancreatic progenitors (PPs), due to downregulation of PDX1-bound genes, including transcription factors MNX1 and PDX1 as well as insulin resistance gene CES1. Additionally, both PDX1P33T/+ and PDX1P33T/P33T mutations in PPs reduced the expression of PDX1-bound genes including the long-noncoding RNA, MEG3 and the imprinted gene NNAT , both involved in insulin synthesis and secretion. Our results reveal mechanistic details of how common coding mutations in PDX1 impair human pancreatic endocrine lineage formation and β-cell function and contribute to the predisposition for diabetes. • Missense mutations in the transactivation domain reduce PDX1 target gene expression. • Lack of PDX1 target gene activation impairs both β-cell development and function. • Common PDX1 coding mutations likely predispose for diabetes. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
5. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
- Author
-
Wang, Xianming, Sterr, Michael, Burtscher, Ingo, Chen, Shen, Hieronimus, Anja, Machicao, Fausto, Staiger, Harald, Häring, Hans-Ulrich, Lederer, Gabriele, Meitinger, Thomas, Cernilogar, Filippo M., Schotta, Gunnar, Irmler, Martin, Beckers, Johannes, Hrabě de Angelis, Martin, Ray, Michael, Wright, Christopher V.E., Bakhti, Mostafa, and Lickert, Heiko
- Abstract
Objective Homozygous loss-of-function mutations in the gene coding for the homeobox transcription factor (TF) PDX1 leads to pancreatic agenesis, whereas heterozygous mutations can cause Maturity-Onset Diabetes of the Young 4 (MODY4). Although the function of Pdx1 is well studied in pre-clinical models during insulin-producing β-cell development and homeostasis, it remains elusive how this TF controls human pancreas development by regulating a downstream transcriptional program. Also, comparative studies of PDX1 binding patterns in pancreatic progenitors and adult β-cells have not been conducted so far. Furthermore, many studies reported the association between single nucleotide polymorphisms (SNPs) and T2DM, and it has been shown that islet enhancers are enriched in T2DM-associated SNPs. Whether regions, harboring T2DM-associated SNPs are PDX1 bound and active at the pancreatic progenitor stage has not been reported so far. Methods In this study, we have generated a novel induced pluripotent stem cell (iPSC) line that efficiently differentiates into human pancreatic progenitors (PPs). Furthermore, PDX1 and H3K27ac chromatin immunoprecipitation sequencing (ChIP-seq) was used to identify PDX1 transcriptional targets and active enhancer and promoter regions. To address potential differences in the function of PDX1 during development and adulthood, we compared PDX1 binding profiles from PPs and adult islets. Moreover, combining ChIP-seq and GWAS meta-analysis data we identified T2DM-associated SNPs in PDX1 binding sites and active chromatin regions. Results ChIP-seq for PDX1 revealed a total of 8088 PDX1-bound regions that map to 5664 genes in iPSC-derived PPs. The PDX1 target regions include important pancreatic TFs, such as PDX1 itself, RFX6 , HNF1B , and MEIS1, which were activated during the differentiation process as revealed by the active chromatin mark H3K27ac and mRNA expression profiling, suggesting that auto-regulatory feedback regulation maintains PDX1 expression and initiates a pancreatic TF program. Remarkably, we identified several PDX1 target genes that have not been reported in the literature in human so far, including RFX3, required for ciliogenesis and endocrine differentiation in mouse, and the ligand of the Notch receptor DLL1 , which is important for endocrine induction and tip-trunk patterning. The comparison of PDX1 profiles from PPs and adult human islets identified sets of stage-specific target genes, associated with early pancreas development and adult β-cell function, respectively. Furthermore, we found an enrichment of T2DM-associated SNPs in active chromatin regions from iPSC-derived PPs. Two of these SNPs fall into PDX1 occupied sites that are located in the intronic regions of TCF7L2 and HNF1B . Both of these genes are key transcriptional regulators of endocrine induction and mutations in cis-regulatory regions predispose to diabetes. Conclusions Our data provide stage-specific target genes of PDX1 during in vitro differentiation of stem cells into pancreatic progenitors that could be useful to identify pathways and molecular targets that predispose for diabetes. In addition, we show that T2DM-associated SNPs are enriched in active chromatin regions at the pancreatic progenitor stage, suggesting that the susceptibility to T2DM might originate from imperfect execution of a β-cell developmental program. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
- Author
-
Berti, Lucia, Irmler, Martin, Zdichavsky, Marty, Meile, Tobias, Böhm, Anja, Stefan, Norbert, Fritsche, Andreas, Beckers, Johannes, Königsrainer, Alfred, Häring, Hans-Ulrich, de Angelis, Martin Hrabě, and Staiger, Harald
- Abstract
Objective Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility that FGF21 is a cross-talker between liver and adipose tissue in MUHO. Furthermore, we studied the effects of chronic FGF21 treatment on adipocyte differentiation, lipid storage, and adipokine secretion. Methods In 20 morbidly obese donors of abdominal subcutaneous fat biopsies discordant for their whole-body insulin sensitivity (hereby classified as MHO or MUHO subjects), serum FGF21 was quantified. The impact of chronic FGF21 treatment on differentiation, lipid accumulation, and adipokine release was assessed in isolated preadipocytes differentiated in vitro . Results Serum FGF21 concentrations were more than two-fold higher in MUHO as compared to MHO subjects (457 ± 378 vs. 211 ± 123 pg/mL; p < 0.05). FGF21 treatment of human preadipocytes for the entire differentiation period was modestly lipogenic (+15%; p < 0.05), reduced the expression of key adipogenic transcription factors ( PPARG and CEBPA , −15% and −40%, respectively; p < 0.01 both), reduced adiponectin expression (−20%; p < 0.05), markedly reduced adiponectin release (−60%; p < 0.01), and substantially increased leptin (+60%; p < 0.01) and interleukin-6 (+50%; p < 0.001) release. Conclusions The hepatokine FGF21 exerts weak lipogenic and anti-adipogenic actions and marked adiponectin-suppressive and leptin and interleukin-6 release-promoting effects in human differentiating preadipocytes. Together with the higher serum concentrations in MUHO subjects, our findings reveal FGF21 as a circulating factor promoting the development of metabolically unhealthy adipocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Stem-Cell-like Properties and Epithelial Plasticity Arise as Stable Traits after Transient Twist1 Activation.
- Author
-
Schmidt, Johanna M., Panzilius, Elena, Bartsch, Harald S., Irmler, Martin, Beckers, Johannes, Kari, Vijayalakshmi, Linnemann, Jelena R., Dragoi, Diana, Hirschi, Benjamin, Kloos, Uwe J., Sass, Steffen, Theis, Fabian, Kahlert, Steffen, Johnsen, Steven A., Sotlar, Karl, and Scheel, Christina H.
- Abstract
Summary Master regulators of the epithelial-mesenchymal transition such as Twist1 and Snail1 have been implicated in invasiveness and the generation of cancer stem cells, but their persistent activity inhibits stem-cell-like properties and the outgrowth of disseminated cancer cells into macroscopic metastases. Here, we show that Twist1 activation primes a subset of mammary epithelial cells for stem-cell-like properties, which only emerge and stably persist following Twist1 deactivation. Consequently, when cells undergo a mesenchymal-epithelial transition (MET), they do not return to their original epithelial cell state, evidenced by acquisition of invasive growth behavior and a distinct gene expression profile. These data provide an explanation for how transient Twist1 activation may promote all steps of the metastatic cascade; i.e., invasion, dissemination, and metastatic outgrowth at distant sites. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
8. Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis.
- Author
-
Kahle, Melanie, Horsch, Marion, Fridrich, Barbara, Seelig, Anett, Schultheiß, Jürgen, Leonhardt, Jörn, Irmler, Martin, Beckers, Johannes, Rathkolb, Birgit, Wolf, Eckhard, Franke, Nicole, Gailus-Durner, Valérie, Fuchs, Helmut, de Angelis, Martin Hrabě, and Neschen, Susanne
- Abstract
Abstract: Genetic predisposition and environmental factors contribute to an individual's susceptibility to develop hepatosteatosis. In a systematic, comparative survey we focused on genotype-dependent and -independent adaptations early in the pathogenesis of hepatosteatosis by characterizing C3HeB/FeJ, C57BL/6NTac, C57BL/6J, and 129P2/OlaHsd mice after 7, 14, or 21 days high-fat-diet exposure. Strain-specific metabolic responses during diet challenge and liver transcript signatures in mild hepatosteatosis outline the suitability of particular strains for investigating the relationship between hepatocellular lipid content and inflammation, glucose homeostasis, insulin action, or organelle physiology. Genetic background-independent transcriptional adaptations in liver paralleling hepatosteatosis suggest an early increase in the organ's vulnerability to oxidative stress damage what could advance hepatosteatosis to steatohepatitis. “Universal” adaptations in transcript signatures and transcription factor regulation in liver link insulin resistance, type 2 diabetes mellitus, cancer, and thyroid hormone metabolism with hepatosteatosis, hence, facilitating the search for novel molecular mechanisms potentially implicated in the pathogenesis of human non-alcoholic-fatty-liver-disease. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
9. Gut HIF2α signaling is increased after VSG, and gut activation of HIF2α decreases weight, improves glucose, and increases GLP-1 secretion.
- Author
-
Evers, Simon S., Shao, Yikai, Ramakrishnan, Sadeesh K., Shin, Jae Hoon, Bozadjieva-Kramer, Nadejda, Irmler, Martin, Stemmer, Kerstin, Sandoval, Darleen A., Shah, Yatrik M., and Seeley, Randy J.
- Abstract
Gastric bypass and vertical sleeve gastrectomy (VSG) remain the most potent and durable treatments for obesity and type 2 diabetes but are also associated with iron deficiency. The transcription factor HIF2α, which regulates iron absorption in the duodenum, increases following these surgeries. Increasing iron levels by means of dietary supplementation or hepatic hepcidin knockdown does not undermine the effects of VSG, indicating that metabolic improvements following VSG are not secondary to lower iron levels. Gut-specific deletion of Vhl results in increased constitutive duodenal HIF2α signaling and produces a profound lean, glucose-tolerant phenotype that mimics key effects of VSG. Interestingly, intestinal Vhl deletion also results in increased intestinal secretion of GLP-1, which is essential for these metabolic benefits. These data demonstrate a role for increased duodenal HIF2α signaling in regulating crosstalk between iron-regulatory systems and other aspects of systemic physiology important for metabolic regulation. [Display omitted] • Bariatric surgeries result in reduced iron despite upregulation of absorption pathways • Dietary or genetic manipulation to increase iron does not affect VSG effectiveness • Genetic activation of intestinal HIF2α results in improved body fat glucose tolerance • Intestinal HIF2α activation increases GLP-1 secretion, which mediates effects Bariatric surgery remains the most potent treatment for obesity and type 2 diabetes but also reduces iron levels. Evers et al. find that the machinery for absorbing iron is activated after VSG. Activation of this machinery recapitulates multiple effects of VSG. These findings may lead to less invasive therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability.
- Author
-
Hoene, Miriam, Kappler, Lisa, Kollipara, Laxmikanth, Hu, Chunxiu, Irmler, Martin, Bleher, Daniel, Hoffmann, Christoph, Beckers, Johannes, Hrabě de Angelis, Martin, Häring, Hans-Ulrich, Birkenfeld, Andreas L., Peter, Andreas, Sickmann, Albert, Xu, Guowang, Lehmann, Rainer, and Weigert, Cora
- Abstract
Liver mitochondria adapt to high-calorie intake. We investigated how exercise alters the early compensatory response of mitochondria, thus preventing fatty liver disease as a long-term consequence of overnutrition. We compared the effects of a steatogenic high-energy diet (HED) for six weeks on mitochondrial metabolism of sedentary and treadmill-trained C57BL/6N mice. We applied multi-OMICs analyses to study the alterations in the proteome, transcriptome, and lipids in isolated mitochondria of liver and skeletal muscle as well as in whole tissue and examined the functional consequences by high-resolution respirometry. HED increased the respiratory capacity of isolated liver mitochondria, both in sedentary and in trained mice. However, proteomics analysis of the mitochondria and transcriptomics indicated that training modified the adaptation of the hepatic metabolism to HED on the level of respiratory complex I, glucose oxidation, pyruvate and acetyl-CoA metabolism, and lipogenesis. Training also counteracted the HED-induced glucose intolerance, the increase in fasting insulin, and in liver fat by lowering diacylglycerol species and c-Jun N-terminal kinase (JNK) phosphorylation in the livers of trained HED-fed mice, two mechanisms that can reverse hepatic insulin resistance. In skeletal muscle, the combination of HED and training improved the oxidative capacity to a greater extent than training alone by increasing respiration of isolated mitochondria and total mitochondrial protein content. We provide a comprehensive insight into the early adaptations of mitochondria in the liver and skeletal muscle to HED and endurance training. Our results suggest that exercise disconnects the HED-induced increase in mitochondrial substrate oxidation from pyruvate and acetyl-CoA-driven lipid synthesis. This could contribute to the prevention of deleterious long-term effects of high fat and sugar intake on hepatic mitochondrial function and insulin sensitivity. • High-energy diet promotes mitochondrial respiration in liver independent of training. • High-energy diet combined with training disconnects substrate oxidation from lipid synthesis. • High-energy diet combined with training reduces complex I formation in the liver. • Trained skeletal muscle unburdens the liver from substrate overload. • Comprehensive resource of mitochondrial adaptations to high-energy diet and training. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Correlation guided Network Integration (CoNI) reveals novel genes affecting hepatic metabolism.
- Author
-
Klaus, Valentina S., Schriever, Sonja C., Monroy Kuhn, José Manuel, Peter, Andreas, Irmler, Martin, Tokarz, Janina, Prehn, Cornelia, Kastenmüller, Gabi, Beckers, Johannes, Adamski, Jerzy, Königsrainer, Alfred, Müller, Timo D., Heni, Martin, Tschöp, Matthias H., Pfluger, Paul T., and Lutter, Dominik
- Abstract
Technological advances have brought a steady increase in the availability of various types of omics data, from genomics to metabolomics. Integrating these multi-omics data is a chance and challenge for systems biology; yet, tools to fully tap their potential remain scarce. We present here a fully unsupervised and versatile correlation-based method – termed Correlation guided Network Integration (CoNI) – to integrate multi-omics data into a hypergraph structure that allows for the identification of effective modulators of metabolism. Our approach yields single transcripts of potential relevance that map to specific, densely connected, metabolic subgraphs or pathways. By applying our method on transcriptomics and metabolomics data from murine livers under standard Chow or high-fat diet, we identified eleven genes with potential regulatory effects on hepatic metabolism. Five candidates, including the hepatokine INHBE, were validated in human liver biopsies to correlate with diabetes-related traits such as overweight, hepatic fat content, and insulin resistance (HOMA-IR). Our method's successful application to an independent omics dataset confirmed that the novel CoNI framework is a transferable, entirely data-driven, flexible, and versatile tool for multiple omics data integration and interpretation. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. The Aryl Hydrocarbon Receptor Pathway Defines the Time Frame for Restorative Neurogenesis.
- Author
-
Di Giaimo, Rossella, Durovic, Tamara, Barquin, Pablo, Kociaj, Anita, Lepko, Tjasa, Aschenbroich, Sven, Breunig, Christopher T., Irmler, Martin, Cernilogar, Filippo M., Schotta, Gunnar, Barbosa, Joana S., Trümbach, Dietrich, Baumgart, Emily Violette, Neuner, Andrea M., Beckers, Johannes, Wurst, Wolfgang, Stricker, Stefan H., and Ninkovic, Jovica
- Abstract
Summary Zebrafish have a high capacity to replace lost neurons after brain injury. New neurons involved in repair are generated by a specific set of glial cells, known as ependymoglial cells. We analyze changes in the transcriptome of ependymoglial cells and their progeny after injury to infer the molecular pathways governing restorative neurogenesis. We identify the aryl hydrocarbon receptor (AhR) as a regulator of ependymoglia differentiation toward post-mitotic neurons. In vivo imaging shows that high AhR signaling promotes the direct conversion of a specific subset of ependymoglia into post-mitotic neurons, while low AhR signaling promotes ependymoglial proliferation. Interestingly, we observe the inactivation of AhR signaling shortly after injury followed by a return to the basal levels 7 days post injury. Interference with timely AhR regulation after injury leads to aberrant restorative neurogenesis. Taken together, we identify AhR signaling as a crucial regulator of restorative neurogenesis timing in the zebrafish brain. Graphical Abstract Highlights • Aryl hydrocarbon receptor (AhR) pathway is crucial for brain regeneration • High AhR levels promote conversion of ependymoglia to neurons during regeneration • Low AhR levels promote ependymoglial proliferation in the injured brain • AhR levels set the proper timing of restorative neurogenesis Zebrafish have a high capacity to replace lost neurons after brain injury. Di Giaimo et al. identify the aryl hydrocarbon receptor (AhR) as a crucial regulator of restorative neurogenesis timing in the zebrafish brain. Interference with timely AhR regulation after injury leads to aberrant restorative neurogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Direct physical interaction between the Caenorhabditis elegans `death proteins' CED-3 and CED-4
- Author
-
Irmler, Martin, Hofmann, Kay, Vaux, David, and Tschopp, Jürg
- Published
- 1997
- Full Text
- View/download PDF
14. Understanding gene functions and disease mechanisms: Phenotyping pipelines in the German Mouse Clinic.
- Author
-
Fuchs, Helmut, Aguilar-Pimentel, Juan Antonio, Amarie, Oana V., Becker, Lore, Calzada-Wack, Julia, Cho, Yi-Li, Garrett, Lillian, Hölter, Sabine M., Irmler, Martin, Kistler, Martin, Kraiger, Markus, Mayer-Kuckuk, Philipp, Moreth, Kristin, Rathkolb, Birgit, Rozman, Jan, da Silva Buttkus, Patricia, Treise, Irina, Zimprich, Annemarie, Gampe, Kristine, and Hutterer, Christine
- Subjects
- *
GENE flow , *MECHANISM (Philosophy) , *IMMUNE system , *IMMUNOLOGY , *RESPIRATORY organs - Abstract
Since decades, model organisms have provided an important approach for understanding the mechanistic basis of human diseases. The German Mouse Clinic (GMC) was the first phenotyping facility that established a collaboration-based platform for phenotype characterization of mouse lines. In order to address individual projects by a tailor-made phenotyping strategy, the GMC advanced in developing a series of pipelines with tests for the analysis of specific disease areas. For a general broad analysis, there is a screening pipeline that covers the key parameters for the most relevant disease areas. For hypothesis-driven phenotypic analyses, there are thirteen additional pipelines with focus on neurological and behavioral disorders, metabolic dysfunction, respiratory system malfunctions, immune-system disorders and imaging techniques. In this article, we give an overview of the pipelines and describe the scientific rationale behind the different test combinations. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. The global gene expression profile of the secondary transition during pancreatic development.
- Author
-
Willmann, Stefanie J., Mueller, Nikola S., Engert, Silvia, Sterr, Michael, Burtscher, Ingo, Raducanu, Aurelia, Irmler, Martin, Beckers, Johannes, Sass, Steffen, Theis, Fabian J., and Lickert, Heiko
- Subjects
- *
GENE expression , *PANCREAS development , *TISSUE engineering , *ENDOCRINE disruptors , *EPITHELIUM - Abstract
Pancreas organogenesis is a highly dynamic process where neighboring tissue interactions lead to dynamic changes in gene regulatory networks that orchestrate endocrine, exocrine, and ductal lineage formation. To understand the spatio-temporal regulatory logic we have used the Forkhead transcription factor Foxa2-Venus fusion (FVF) knock-in reporter mouse to separate the FVF + pancreatic epithelium from the FVF − surrounding tissue (mesenchyme, neurons, blood, and blood vessels) to perform a genome-wide mRNA expression profiling at embryonic days (E) 12.5–15.5. Annotating genes and molecular processes suggest that FVF marks endoderm-derived multipotent epithelial progenitors at several lineage restriction steps, when the bulk of endocrine, exocrine and ductal cells are formed during the secondary transition. In the pancreatic epithelial compartment, we identified most known endocrine and exocrine lineage determining factors and diabetes-associated genes, but also unknown genes with spatio-temporal regulated pancreatic expression. In the non-endoderm-derived compartment, we identified many well-described regulatory genes that are not yet functionally annotated in pancreas development, emphasizing that neighboring tissue interactions are still ill defined. Pancreatic expression of over 635 genes was analyzed with the mRNA in situ hybridization Genepaint public database. This validated the quality of the profiling data set and identified hundreds of genes with spatially restricted expression patterns in the pancreas. Some of these genes are also targeted by pancreatic transcription factors and show active chromatin marks in human islets of Langerhans. Thus, with the highest spatio-temporal resolution of a global gene expression profile during the secondary transition, our study enables to shed light on neighboring tissue interactions, developmental timing and diabetes gene regulation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.
- Author
-
Franko, Andras, von Kleist-Retzow, Jürgen-Christoph, Neschen, Susanne, Wu, Moya, Schommers, Philipp, Böse, Marlen, Kunze, Alexander, Hartmann, Ursula, Sanchez-Lasheras, Carmen, Stoehr, Oliver, Huntgeburth, Michael, Brodesser, Susanne, Irmler, Martin, Beckers, Johannes, de Angelis, Martin Hrabé, Paulsson, Mats, Schubert, Markus, and Wiesner, Rudolf J.
- Subjects
- *
INSULIN resistance , *PEOPLE with diabetes , *LABORATORY mice , *MITOCHONDRIAL pathology , *LIVER diseases , *HIGH-fat diet , *OBESITY - Abstract
Background & Aims: To determine if diabetic and insulin-resistant states cause mitochondrial dysfunction in liver or if there is long term adaptation of mitochondrial function to these states, mice were (i) fed with a high-fat diet to induce obesity and T2D (HFD), (ii) had a genetic defect in insulin signaling causing whole body insulin resistance, but not full blown T2D (IR/IRS-1 +/− mice), or (iii) were analyzed after treatment with streptozocin (STZ) to induce a T1D-like state. Methods: Hepatic lipid levels were measured by thin layer chromatography. Mitochondrial respiratory chain (RC) levels and function were determined by Western blot, spectrophotometric, oxygen consumption and proton motive force analysis. Gene expression was analyzed by real-time PCR and microarray. Results: HFD caused insulin resistance and hepatic lipid accumulation, but RC was largely unchanged. Livers from insulin resistant IR/IRS-1 +/− mice had normal lipid contents and a normal RC, but mitochondria were less well coupled. Livers from severely hyperglycemic and hypoinsulinemic STZ mice had massively depleted lipid levels, but RC abundance was unchanged. However, liver mitochondria isolated from these animals showed increased abundance and activity of the RC, which was better coupled. Conclusions: Insulin resistance, induced either by obesity or genetic manipulation and steatosis do not cause mitochondrial dysfunction in mouse liver. Also, mitochondrial dysfunction is not a prerequisite for liver steatosis. However, severe insulin deficiency and high blood glucose levels lead to an enhanced performance and better coupling of the RC. This may represent an adaptation to fuel overload and the high energy-requirement of an unsuppressed gluconeogenesis. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
17. MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma
- Author
-
Baumhoer, Daniel, Zillmer, Stephanie, Unger, Kristian, Rosemann, Michael, Atkinson, Michael J., Irmler, Martin, Beckers, Johannes, Siggelkow, Heide, von Luettichau, Irene, Jundt, Gernot, Smida, Jan, and Nathrath, Michaela
- Subjects
- *
MICRORNA , *GENE expression , *TUMOR suppressor genes , *ONCOGENES , *OSTEOSARCOMA , *CELL lines , *CELL differentiation - Abstract
Osteosarcomas are genetically complex tumors with abundant structural and numerical alterations. The molecular pathogenesis of the disease is, however, still poorly understood. Aside from various oncogenes and tumor suppressor genes, deregulated microRNAs (miRNAs) are known to influence tumor development and biology. We therefore investigated six well-established osteosarcoma cell lines (HOS58, U2-OS, Saos-2, MNNG/HOS, SJSA-1, and MG-63) for genome-wide miRNA expression (miRBase Version 15.0, http://www.mirbase.org/) and correlated our findings with gene expression. Cultured osteoblasts (hFOB 1.19) and mesenchymal stem cells (L87/4) were used as normal references. Focusing only on miRNAs that were deregulated in the majority of osteosarcoma cell lines, we identified several miRNAs with oncogenic and tumor suppressor properties, including various members of the oncogenic miR-17-92 cluster. In addition, several genes involved in differentiation (RGMB, LRRC17), cell cycle control (CCNE1), and apoptosis (LIMA1, CAMK2N1) were found to be deregulated in osteosarcoma cell lines, most likely due to altered miRNA expression patterns. Our findings indicate a crucial impact of deregulated miRNAs with consecutive changes in gene expression in osteosarcomas, which strongly suggests pathogenetic and potentially therapeutic implications. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. Selective Expression of FLIP in Malignant Melanocytic Skin Lesions.
- Author
-
Bullani, Roberto R., Huard, Bertrand, Viard-Leveugle, Isabelle, Byers, H. Randolph, Irmler, Martin, Saurat, Jean-Hilaire, Tschopp, Jürg, and French, Lars E.
- Subjects
- *
CHEMICAL inhibitors , *CELL death , *MELANOMA , *IMMUNOHISTOCHEMISTRY , *APOPTOSIS - Abstract
FLIP (FLICE Inhibitory Protein) is a recently identified intracellular inhibitor of caspase-8 activation that potently inhibits cell death mediated by all death receptors including Fas and TRAIL. FLIP has recently been shown to favor tumor growth and immune escape in mouse tumor models. We analyzed FLIP expression by immunohistochemistry in a panel of 61 benign and malignant human melanocytic skin lesions. FLIP expression was undetectable in all but one benign melanocytic lesion (31/32, 97%). In contrast, FLIP was strongly expressed in most melanomas (24/29 = 83%). Overexpression of FLIP by transfection in a Fas- and TRAIL-sensitive human melanoma cell line rendered this cell line more resistant to death mediated by both TRAIL and FasL. Selective expression of FLIP by human melanomas may confer in vivo resistance to FasL and TRAIL, thus representing an additional mechanism by which melanoma cells escape immune destruction. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
19. MSX1 promotes melanoma progression via neural crest-like reprogramming.
- Author
-
Fukunaga-Kalabis, Mizuho, Heppt, Markus V., Wang, Joshua X., Hristova, Denitsa M., Wei, Zhi, Irmler, Martin, Berking, Carola, Besch, Robert, Beckers, Johannes, Rauscher, Frank J., Fisher, David E., and Herlyn, Meenhard
- Subjects
- *
HOMEOBOX proteins , *MELANOMA , *CANCER invasiveness , *NEURAL crest , *DERMATOLOGY - Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.